Nortran Pharmaceutical -NRT.V Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Paul S. who wrote (497)	4/29/1998 11:36:00 AM
From: Paul S.	Read Replies (1) of 1185

Just saw this in the Financial Post. MARKET ACTION Nortran Pharmaceuticals Inc. (NRT/VSE), up $0.44 to $2.70, on volume of 935,150 shares. Shares of the Vancouver-based drug-development company rose 19% yesterday in triple the average daily volume to close at a 52-week high. The company develops drugs to prevent irregular heartbeats - a condition which in some cases can lead to sudden death - and is rumored to be negotiating a licensing deal with a major pharmaceutical maker soon, said Brook Riggins, an analyst with Canaccord Capital Corp. Also, the stock has been rising on Monday's announced brokered private placement of five million special warrants, Riggins said.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next